¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"minimal auditory threshold"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® auditory tube ÇÑ±Û ±ÍÀεΰü
¼³¸í   
  ÄÚ ¾È°ú °¡¿îµ¥ ±Í¸¦ ¿¬°áÇϴ °ü. ±Í´Â Å©°Ô ¹Ù±ù±Í, °¡¿îµ¥±Í, ¼Ó±ÍÀÇ 3ºÎºÐÀ¸·Î ³ª´©´Âµ¥ ¹Ù±ù±Í¶ó°í Çϴ °ÍÀº ¼Ò¸®¸¦ °í¸·±îÁö Àü´ÞÇϴ ¹Ù±ù±Ó±æ ºÎºÐÀ» ¸»ÇÑ´Ù. ±×¸®°í °¡¿îµ¥±Í¶õ °í¸·¿¡¼­ ¼Ó±Í »çÀÌÀÇ °ø°£À¸·Î, ¿©±â¿¡´Â ¼Ò¸®¸¦ ´À³¢´Â ´ÞÆØÀ̱îÁö °í¸·ÀÇ Áøµ¿À» Àü´ÞÇØ Áִ ÀÛÀº »ÀÀΠ3°³ÀÇ ±Ó¼Ó»À°¡ ÀÖ´Ù. ¼Ó±Í¶õ ¼Ò¸®¸¦ Á÷Á¢ ´À³¢´Â ±â°üÀΠ´ÞÆØÀÌ, ÆòÇü°¨°¢À» ´ã´çÇϴ ¹Ý°í¸®°ü, ±¸Çü³¶(saccule), Å¸¿ø³¶(utricle)ÀÌ Àִ °÷À» ¸»ÇÑ´Ù. ÀÌ ±â°üÀÇ ±â´ÉÀº °¡¿îµ¥±Í¿Í ¿Ü°èÀÇ ¾Ð·Â Â÷À̸¦ ¾ø¾ÖÁִ ¿ªÇÒÀ» ÇÑ´Ù. ±×·¯³ª ÁßÀÌ¿°(ÁßÀÌ¿¡ ¿°ÁõÀÌ »ý±â´Â °Í)ÀÇ Åë·Î·Î ÀÌ¿ëµÉ ¼ö°¡ ÀÖ´Ù.
¿µ¹® auditory nerve ÇÑ±Û Ã»½Å°æ
¼³¸í   
  ±Í¿¡¼­ °¨ÁöµÈ Ã»°¢ÀÇ ½ÅÈ£¸¦ ´ë³ú·Î º¸³»´Â ¿ªÇÒÀ» Çϴ ½Å°æ. ´ÞÆØÀ̽Űæ¶ó°í ºÒ¸®±âµµ ÇÑ´Ù. ±×°ÍÀº ¼Ò¸®¸¦ Àü±âÀû ½ÅÈ£·Î ¹Ù²Ù¾î ½Å°æÀ¸·Î Àü´ÞÇØ Áִ ´ÞÆØÀÌÀÇ Áý°°ÀÌ »ý±ä ±â°üÀ» ´ÞÆØÀ̶ó°í ºÎ¸£±â ¶§¹®ÀÌ´Ù.
  
  Ã»½Å°æ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • differential threshold
    Â÷º°¹®Åΰª
  • discrimination threshold
    ½Äº°¹®Åΰª
  • high-threshold cell
    °í¹®Åΰª¼¼Æ÷
  • masking threshold
    °¡¸é¹®Åΰª, Â÷Æó¿ªÄ¡
  • mechanical threshold
    ±â°èÀû¹®Åΰª
  • quasi-threshold
    À¯»ç¹®ÅÎ, ÁØ¿ªÄ¡
  • reaction threshold
    ¹ÝÀÀ¹®Åΰª
  • radiation threshold
    ¹æ»ç¼±¹®ÅÎ
  • spatial threshold
    °ø°£¹®Åΰª
  • speech reception threshold
    À½¼ºÃ»Ãë¹®Åΰª
  • speech recognition threshold
    ¾ð¾î°¨Áö¹®Åΰª
  • spike threshold
    ±ØÆÄ¿ªÄ¡
  • stimulus threshold
    Àڱع®Åΰª, ÀڱؿªÄ¡
  • temporary threshold shift
    ÀϽÃÀû¹®Åΰªº¯À§
  • minimal
    ÃÖ¼Ò-
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal invasive surgery
    ÃÖ¼Òħ½À¼ö¼ú
  • threshold stimulus
    ¹®ÅÎÀÚ±Ø, ¿ªÄ¡ÀÚ±Ø
  • threshold
    ¹®ÅÎ, ¹®Åΰª
  • reaction threshold
    ¹ÝÀÀ¹®Åΰª, ¹ÝÀÀ¿ªÄ¡
  • threshold value
    ¹®Åΰª, ¿ªÄ¡
  • auditory cortex
    û°¢°ÑÁú
  • auditory hallucination
    ȯû
  • auditory macula
    û¹Ý
  • auditory evoked potential
    µè±âÀ¯¹ßÀüÀ§, û°¢À¯¹ßÀüÀ§
  • auditory training
    û°¢ÈÆ·Ã
  • auditory tube
    ±Í°ü, ±ÍÀεΰü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal visible angle
    Ãּҽð¢
  • minimal alveolar concentration
    ÃÖ¼ÒÆóÆ÷³»³óµµ
  • minimal anesthetic concentration
    ÃÖ¼Ò¸¶Ãë³óµµ
  • minimal bactericidal concentration
    ÃÖ¼Ò»ì±Õ³óµµ
  • minimal blocking concentration
    ÃÖ¼ÒÂ÷´Ü³óµµ
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • minimal inhibitory concentration
    ÃÖÀú¾ïÁ¦³óµµ, ÃÖÀúÀúÁö³óµµ
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö, ¹Ì¼Ò³ú±â´ÉÀå¾Ö
  • minimal change disease
    ÃÖ¼Òº¯È­ÄáÆÏº´Áõ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • minimal erytherma dose
    ÃÖ¼ÒÈ«¹Ý¼±·®
  • minimal lethal dose
    ÃÖ¼ÒÄ¡»ç·®, ÃÖ¼ÒÄ¡»ç¼±·®
  • minimal enhancement
    ¹Ì¹ÌÇÑÁ¶¿µÁõ°­, °æµµÁ¶¿µÁõ°­
  • minimal current gradient
    ÃÖ¼ÒÀü·ù±â¿ï±â, ÃÖ¼ÒÀü·ù°æ»ç
  • minimal tension line
    ÃÖ¼ÒÀå·Â¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Kobraks minimal stimulation
    ÄÚºê¶ô¾àÀڱعý
  • High-threshold cells
    °í¿ªÄ¡¼¼Æ÷(ÍÔ ö·á¬øà)
  • hearing, threshold of
    °¡Ã»¿ªÄ¡
  • quasi-threshold
    À¯»ç¿ªÄ¡
  • reaction threshold
    ¹ÝÀÀ¿ªÄ¡(ÚãëëÚÊö·).
  • relational threshold
    Â÷º°¿ªÄ¡.
  • acoustic radiation =auditory r.
    û¹æ»ç
  • acute auditory hallucinosis
    ±Þ¼º ȯûÁõ
  • aphasia, auditory
    û°¢¼º ½Ç¾îÁõ
  • gland of auditory tube
    ±ÍÀεΰü»ù
  • glands of auditory tube
    ±ÍÀεΰü»ù
  • groove for auditory tube
    À̰ü±¸, ÁßÀ̰ü°í¶û
  • hallucination, auditory
    ȯû(ü³ôé)
  • hearing, sense of =auditory sensation
    û°¢
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal auditory threshold
    ÃÖ¼Ò°¡Ã»¿ªÄ¡(õÌ á³Ê¦ôéÚÊö·).
  • minimal auditory threshold
    ÃÖ¼Ò°¡Ã»¿ªÄ¡
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • auditory threshold
    û°¢¿ªÄ¡(¡­Ú¿ö·)
  • minimal air
    ÃÖ¼Ò°ø±â.
  • minimal angle resolution
    ÃÖ¼Ò°¢ºÐÇØ´É.
  • minimal bactericidal concentration (MBC)
    »ì±ÕÃÖ¼Ò³óµµ
  • minimal blood pressure
    ÃÖ¼ÒÇ÷¾Ð.
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö.
  • minimal brain dysfunction
    ¹Ì¼Ò³ú±â´ÉÀå¾Ö(Ú°á³ÒàѦÒöî¡äô)
  • minimal change disease
    ¹Ì¼Òº¯È­ »ç±¸Ã¼½Å¿°
  • minimal change disease
    ¹Ì¼Ò º´º¯½ÅÁõ(ڰܻ᳠ܨãìñø)
  • minimal current gradient
    ÃÖ¼ÒÀü·ù°æ»ç(¡­ï³êüÌËÞØ).
  • minimal current gradient
    ÃÖ¼ÒÀü·ù±¸¹è(¡­ï³êüÎþÛÕ).
  • minimal daily requirement
    ÃÖ¼Ò¿µ¾çÇʿ䷮(õÌá³ç½å×ù±é©åÖ), ÃÖ¼ÒÀÏÀϿ䱸·® .
  • minimal daily requirement
    ÃÖ¼Ò¿µ¾çÇʿ䷮(õÌá³ç½å×ù±é©åÖ), ÃÖ¼ÒÀÏÀÏ
  • minimal dose =minimum d.
    ÃÖ¼Ò·®(õÌá³åÖ).
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÀûÁøÅë³óµµ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • (Internal auditory branch)
    (¼Ó±Í±æ°¡Áö)
    [¿¾ ¿ë¾î] ³»À̵µÁö
  • Auditory ossicles
    ±Í¼Ó»À
    [¿¾ ¿ë¾î] À̼Ұñ
  • Auditory tube
    ±ÍÀεΰü
    [¿¾ ¿ë¾î] À̰ü
  • Auditory tube
    ±ÍÀεΰü [ÁßÀ̰ü]
    [¿¾ ¿ë¾î] À̰ü
  • Diverticulum of auditory tube
    ±ÍÀεΰü°çÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] À̰ü°Ô½Ç
  • Groove for auditory tube
    ±ÍÀεΰü°í¶û
    [¿¾ ¿ë¾î] À̰ü±¸
  • Tympanic orifice of auditory tube
    ±ÍÀεΰü°í½Ç±¸¸Û
    [¿¾ ¿ë¾î] À̰ü°í½Ç±¸
  • Semicanal for auditory tube
    ±ÍÀεΰü¹Ý°ü
    [¿¾ ¿ë¾î] À̰ü¹Ý°ü
  • Air cells of auditory tube
    ±ÍÀεΰü¹úÁý
    [¿¾ ¿ë¾î] À̰üºÀ¼Ò
  • Gland of auditory tube
    ±ÍÀεΰü»ù
    [¿¾ ¿ë¾î] À̰ü¼±
  • Glands of auditory tube
    ±ÍÀεΰü»ù
    [¿¾ ¿ë¾î] À̰ü¼±
  • Cartilage of auditory tube
    ±ÍÀεΰü¿¬°ñ
    [¿¾ ¿ë¾î] À̰ü¿¬°ñ
  • Pharyngeal opening of auditory tube
    ±ÍÀεΰüÀεα¸¸Û
    [¿¾ ¿ë¾î] À̰üÀεα¸
  • Pharyngeal orifice of auditory tube
    ±ÍÀεΰüÀεα¸¸Û
    [¿¾ ¿ë¾î] À̰üÀεα¸
  • Isthmus of auditory tube
    ±ÍÀεΰüÀß·è
    [¿¾ ¿ë¾î] À̰üÇù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal medium
    ÃÖ¼Ò¹èÁö(õÌá³ÛÆò¢)
  • minimal stable length
    ÃÖ¼Ò¾ÈÁ¤(õÌá³äÌïÒ) ±æÀÌ
  • beta threshold
    º£Å¸ ¹®ÅÎ
  • cone threshold
    ¿øÃß¼¼Æ÷¿ªÄ¡(ê­õÞá¬øàæ´ö·)
  • renal threshold
    ½Å(ãì)¹®ÅÎ
  • threshold
    ¹®ÅÎ
  • threshold dose
    ¹®ÅÎ ¼±·®(àÊÕá)
  • threshold limit value
    ¹®ÅÎ ÇѰè(ùÚÍ£)°ª
  • threshold of appearance
    ÃâÇö(õóúÞ)¹®ÅÎ
  • threshold of retention
    ÀÜ·ù(íÑ׺)¹®ÅÎ
  • threshold potential
    ¹®ÅÎÀüÀ§ (ï³êÈ)
  • threshold substance
    ¹®Åι°Áú(Úªòõ)
  • visual threshold
    "½Ã°¢(ãÊÊÆ) ¹®ÅÎ, ½Ã°¢ ¿ªÄ¡(ãÊÊÆæ¶ö·)"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • threshold
    ¹®ÅÎ(°ª), ¿ªÄ¡, ÇѰèÄ¡
  • minimal
    ÃÖ¼ÒÀÇ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • minimal enhancement
    ¹Ì¹ÌÇÑÁ¶¿µÁõ°­, °æµµÀÇÁ¶¿µÁõ°­
  • auditory
    û°¢ÀÇ
  • auditory canal
    À̵µ
  • auditory nerve
    û½Å°æ
  • tympanic ostium of auditory tube
    À̰ü°í½Ç±¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MRD maximum rate of depolarization; measles-rindenpest-distemper [virus group]; medical records departme...
MT magnetization transfer; malaria therapy; malignant teratoma; mammary tumor; mammilothalamic tract; m...
TD tabes dorsalis; tardive dyskinesia; T-cell dependent; temporary disability; terminal device; tetanus...
VASC Verbal Auditory Screen for Children; visual-auditory screening
MAV mechanical auditory ventricle; minimal alveolar ventilation; minimum apparent viscosity; movement ar...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EMEM Eagle's Minimal Essential Medium
MAS Minimal Access Surgery
MAC Minimal Alveolar Concentration
MBC Minimal Bactericidal Concentration
MBD Minimal Brain Dysfunction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Eagle`s minimal essential medium
    ÀÌ±Û ¹èÁö
    ¼¼Æ÷ ¹è¾ç¾×ÀÇ ÀÏÁ¾. 3Á¾·ùÀÇ ¾Æ¹Ì³ë»ê°ú 8Á¾·ùÀÇ ºñŸ¹ÎÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¸ç º¸Åë Ç÷û 5% ÀÌÇÏ¿¡¼­ À¯Áö ¹èÁö·Î¼­ »ç¿ëµÇ°í 10-20%ÀÇ Ç÷û ÷°¡·Î ¸¹Àº ¼¼Æ÷´Â ±ØÈ÷ ¾çÈ£ÇÑ ¹ßÀ°À» ³ªÅ¸³½´Ù.
  • minimal
    ÃÖ¼ÒÀÇ
    °¡Àå °¡´É¼ºÀÌ ÀûÀº.
  • minimal dose
    ÃÖ¼Ò·®
  • minimal enhancement
    ¹Ì¹ÌÇÑ Á¶¿µ Áõ°­, °æµµÀÇ Á¶¿µ Áõ°­
  • minimal identifiable odor
    ÃÖ¼Ò ºÐÇØ Ãë°¢
  • minimal requirement
    ÃÖ¼Ò ±Ô°Ý
  • minimal temperature
    ÃÖÀú ¿Âµµ
  • acute auditory hallucinosis
    ±Þ¼º ȯûÁõ
  • auditory aphasia
    û°¢¼º ½Ç¾î
    ³úÀÇ Ã»°¢ ÁßÃß Áúȯ¿¡ ÀÇÇÑ ½Ç¾îÁõ.
  • auditory artery
    ûµ¿¸Æ
  • auditory cartilage
    ÀÌ¿¬°ñ
  • auditory electrooculomotorgram
    û°¢¼º Àü±â ¾È±¸ ¿îµ¿µµ
  • auditory feedback
    û°¢ Çǵå¹é, û°¢Àû µÇ¸ÔÀÓ
  • auditory macula
    û¹Ý
  • auditory meatus
    À̵µ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
auditory threshold The audibility limit of discriminating sound intensity and pitch.
(12 Dec 1998)
minimal Smallest or least, the smallest possible.
Origin: L. Minimus = least
(18 Nov 1997)
minimal air The volume of gas that remains in the lungs and cannot be expelled after they have been removed from the body, or after the chest has been opened.
(05 Mar 2000)
minimal alveolar concentration The end-alveolar concentration of an inhalation anaesthetic which prevents somatic response to a painful stimulus in 50% of individuals; an index of relative potency of inhalation anaesthetics.
Synonym: minimal anaesthetic concentration.
(05 Mar 2000)
minimal amplitude nystagmus Nystagmus of so small an amplitude that it is not detected by the usual clinical tests.
Synonym: minimal amplitude nystagmus.
Origin: micro-+ G. Nystagmos, a nodding
(05 Mar 2000)
minimal anaesthetic concentration The end-alveolar concentration of an inhalation anaesthetic which prevents somatic response to a painful stimulus in 50% of individuals; an index of relative potency of inhalation anaesthetics.
Synonym: minimal anaesthetic concentration.
(05 Mar 2000)
minimal brain dysfunction An inability to control behaviour due to difficulty in processing neural stimuli.
(12 Dec 1998)
minimal-change disease <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
minimal-change nephrotic syndrome <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
minimal deviation melanoma <dermatology, tumour> A malignant melanoma showing less cytologic atypia than is usual in melanoma cells showing asymmetric expansile invasion of the dermis.
(05 Mar 2000)
minimal dose <pharmacology> The smallest amount of a drug or physical procedure that will produce a desired physiologic effect in an adult.
(05 Mar 2000)
minimal infecting dose <microbiology> The smallest quantity of infectious material regularly producing infection; usually expressed as I.D.50, the quantity causing infection in 50% of a suitable series of animals or cells (cell cultures).
(05 Mar 2000)
minimal inhibitory concentration <microbiology, pharmacology> The lowest concentration of antibiotic sufficient to inhibit bacterial growth when tested in vitro.
(05 Mar 2000)
minimal lethal dose <pharmacology> The minimal dose of a toxic substance or infectious agent that is lethal, as assayed in various experimental animals (e.g., the least amount of diphtheria toxin that, on an average, kills a 250-g guinea pig within 96 hours after subcutaneous inoculation).
When followed by a subscript (generally "MLD50"), denotes the minimal dose that is lethal to a certain percentage (e.g., 50%) of animals so assayed, LD05.
See: lethal dose.
(05 Mar 2000)
minimal medium <cell culture> The simplest tissue culture medium that will support the proliferation of normal cells.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • auditory
    ±ÍÀÇ; û°¢ÀÇ
  • threshold
    ¹®Áö¹æ
  • auditory
    ±ÍÀÇ;û°¢ÀÇ
  • threshold
    ¹®Áö¹æ;¹®°£;ÀÔ±¸;Ãâ¹ßÁ¡;½ÃÃÊ;¿ª;at (on) the ~ of ...ÀÇ ½ÃÃÊ¿¡
  • minimal
    ±Ø¼ÒÀÇ; ÃÖÀúÀÇ
  • minimal
    ÃÖ¼ÒÇâ(¼ö)ÀÇ;±Ø¼ÒÀÇ
  • minimal art
    ¹Ì´Ï¸Ö ¾ÆÆ®;ÃÖ¼ÒÇÑÀÇ Á¶Çü ¼ö´ÜÀ¸·Î Á¦ÀÛµÈ ±×¸²;Á¶°¢
  • minimal brain dysfunction
    ¹Ì¼Ò ³ú±â´É Àå¾Ö (¾Æµ¿ÀÇ ÇнÀ Àå¾ÖÀÇ Çϳª)
  • minimal pair
    ÃÖ¼Ò ´ë¾î(bet¿Í bed ó·³ °°Àº À§Ä¡ÀÇ ÇÑ °¡Áö ¼Ò¸®¸¸ ´Ù¸¥ ÇÑ ½ÖÀÇ ³¹¸»)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á